CAM cancer therapies
This article was originally published in The Tan Sheet
Executive Summary
NCCAM will spend 12% of FY 2002 budget (roughly $12.6 mil.) on cancer research projects, according to figures released at Cancer Advisory Panel for Complementary & Alternative Medicine meeting in Bethesda, Md. Feb. 25. Also, CAPCAM Executive Secretary Richard Nahin, PhD, will be replaced by NCCAM Program Officer Mary Ann Richardson, and Chairman Michael Hawkins, MD, Washington (D.C.) Hospital Center, will leave the panel upon expiration of his term March 31. Nahin is leaving his position as NCCAM's extramural research director to become the center's senior advisor on scientific coordination...You may also be interested in...
The Quality Lowdown: On Redeploying Inspectors, API Suppliers Thanks To Coronavirus
US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.
Mallinckrodt's Opioid Resolution Through Generic Unit Bankruptcy May Be 'Test Case'
Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.
Mallinckrodt Finds An Exit Door For Generics In Proposed Opioid Settlement
The company has reached a broad opioid settlement agreement in principle under which its specialty generics subsidiaries would file for Chapter 11 bankruptcy and Mallinckrodt's branded business would operate separately.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: